STEM vs DNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

STEM

46.5
AI Score
VS
STEM Wins

DNA

35.0
AI Score

Investment Advisor Scores

STEM

47score
Recommendation
HOLD

DNA

35score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric STEM DNA Winner
Revenue 62.65M 39.63M STEM
Net Income -33.31M -129.30M STEM
Net Margin -53.2% -326.3% STEM
Operating Income -21.89M -129.92M STEM
ROE 12.4% -30.8% STEM
ROA -11.9% -13.1% STEM
Total Assets 279.77M 990.05M DNA
Cash 38.41M 84.53M DNA
Current Ratio 0.83 4.57 DNA

Relative Price Performance (Last 90 Days)

STEM 1M: -22.0% · 3M: -45.3% DNA 1M: +75.7% · 3M: +22.2%

Current Technical Phase

STEM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.0%), weak momentum, RSI 41

RSI (14): 40.9 · Price: $4.26

DNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 75

RSI (14): 74.6 · Price: $12.35

Fundamentals Snapshot

Metric STEM DNA
Market Cap — —
Forward P/E -0.7 -4.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% -0.5%
Gross Margin 0.4% 0.7%
Operating Margin -0.2% -2.8%
EPS -8.88 -5.19
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, STEM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.